The next generation in stone control therapy
Kidney stones affect more than a million Americans each year. Twelve to 24 million Americans will develop stones in their lifetime and the incidence rate has increased dramatically over the last 20 years with approximately 1,000,000 new stone cases reported each year.
If you've ever suffered from a kidney stone attack you will probably do anything in your power to prevent a recurrence. Luckily there's a specific preventative medical treatment that can greatly reduce the likelihood of your having another stone attack: Urocit-K 15 mEq.
Urocit-K 15 mEq is a maximum-strength alkalinizing agent for simple BID (twice a day) dosing to help prevent stone recurrence. Urocit-K 15 mEq increases urinary pH and urinary citrate, decreases urinary saturation of calcium oxalate, and inhibits calcium.
Strengthen the compliance
Medication management is a proven tool for inhibiting stone formation. Yet patient adherence to multitablet, multidose therapy regimens remains a significant challenge.[8,9]
- Welcome simplicity — more concentrated formula simplifies complex dosing schedules
- Enhanced compliance — in clinical studies, less frequent dosing regimens demonstrate better compliance10
- Comfortable formula — slow-release wax-matrix delivery system for extended release in the GI tract enhances tolerability and provides uniform increases in urinary citrate levels[4,11,12]
Simplify the dose
- Powerful dosage strength — new Urocit-K 15 mEq contains 50% more active ingredient than Urocit-K 10 mEq
- Streamlined control — maintain targeted urinary citrate and urinary pH levels with fewer daily tablets
- Proven efficacy — potassium citrate has been proven to inhibit formation of calcium oxalate and uric acid stones,[1,2,3] with a clinical success rate of more than 90%[4,5,6]
Urocit-K is indicated for the treatment of calcium and uric acid kidney stones. Urocit-K is also available in slow-release wax-matrix tablets in 540 mg and 1080 mg strengths.
- Related Information
- Package Insert»
- Urocit-K Website»
More than 500,000 babies are born too soon each year. Some are so small they struggle to survive. This year, Mission Pharmacal is joining forces with the March of Dimes* as a National Corporate Sponsor to help raise awareness about the growing crisis of premature birth. To learn more and help us fight prematurity, click on the links below. For more than 60 years, Mission Pharmacal has been committed to providing products for healthy women and healthy babies.
Prescription iron therapies are not interchangeable! Ferralet 90 contains carbonyl iron and a unique, gentle formulation that transforms a patient's experience on iron therapy.
Think twice about your choices for treating bacterial vaginosis.
